Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 29 Sept 2021 for Generation Bio Co., €1.1M. Read the official filing
Filing timeline
BuySaleAtlas Venture Associates X, L.P.
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
Atlas Venture Associates X, L.P.: trading record in brief
Filings by Atlas Venture Associates X, L.P. span 2 companies, the busiest being Generation Bio Co. and Kymera Therapeutics, Inc. In total, 5 filings cover trades dated from 21 June 2021 to 27 September 2021.
Every open-market trade on record is a sale: 5 sales worth €16.2M.
The newest entry dates from 29 September 2021: an open-market sale of €1.1M, in Generation Bio Co. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Atlas Venture Associates X, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
51,294 shares@ US$25.7031.0% of flowCommon StockSEC:0001209191-21-058122:0
30,560 shares@ US$25.89118.6% of flowCommon StockSEC:0001209191-21-057719:0
242,133 shares@ US$61.00100.0% of flowCommon StockSEC:0001209191-21-051015:0
26,858 shares@ US$25.7716.0% of flowCommon StockSEC:0001209191-21-043499:0
59,978 shares@ US$24.8234.4% of flowCommon StockSEC:0001209191-21-042857:0
5 of 5 declarations
